Autoimmunity as a double agent in tumor killing and cancer promotion.
about
Extracellular matrix macromolecules: potential tools and targets in cancer gene therapyToward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutationsInterleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease.Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells.Gut microbiota amplifies host-intrinsic conversion from the CD8 T cell lineage to CD4 T cells for induction of mucosal immune tolerance.Depletion of B220(+)NK1.1(+) cells enhances the rejection of established melanoma by tumor-specific CD4(+) T cells.The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity.Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgerInitiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines.Using IFN-γ antibodies to identify the pathogens of fungal rhinosinusitis: A novel immunohistochemical approach.Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research.Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation
P2860
Q26996081-3D559253-5F69-4DE7-9B5E-E5E353C3A069Q28384546-97544AFF-C5D8-4DDF-9968-435CA16F79EBQ34982602-EFD1931E-6261-4BC5-ABE7-919601DC7CC3Q35149564-AF48E836-BD74-41E7-BAEE-F6CE17C6FFADQ35945238-4CBDAEF1-15D4-48D5-A088-FF0B44CE9CB5Q36060315-834380C8-72D3-46C7-A284-68B20F0B20B3Q43097053-07E52851-2C16-417D-B8B7-A034759C9384Q47371631-022B57A7-EE94-4A13-A472-F189F10EC443Q47552742-B1D59504-BF20-435E-8A30-10239B9F6CBDQ48158439-11AB3D3B-6245-4345-8C93-4D63E2FC8544Q49500284-0DA0B61E-0D5D-46CF-84E6-F89BE3F0F7D7Q52564518-B4D2785D-A55D-4D18-B4D5-C4188AA992F4Q57976931-889BB3E2-709E-40AA-BC03-3B95FAE4A954
P2860
Autoimmunity as a double agent in tumor killing and cancer promotion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmunity as a double agent in tumor killing and cancer promotion.
@en
Autoimmunity as a double agent in tumor killing and cancer promotion.
@nl
type
label
Autoimmunity as a double agent in tumor killing and cancer promotion.
@en
Autoimmunity as a double agent in tumor killing and cancer promotion.
@nl
prefLabel
Autoimmunity as a double agent in tumor killing and cancer promotion.
@en
Autoimmunity as a double agent in tumor killing and cancer promotion.
@nl
P2860
P356
P1476
Autoimmunity as a double agent in tumor killing and cancer promotion
@en
P2093
Zhibin Chen
P2860
P356
10.3389/FIMMU.2014.00116
P577
2014-03-18T00:00:00Z